Your browser doesn't support javascript.
loading
Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?
Trono, Paola; Tocci, Annalisa; Musella, Martina; Sistigu, Antonella; Nisticò, Paola.
Afiliación
  • Trono P; Institute of Biochemistry and Cell Biology, National Research Council, Via Ramarini 32, Monterotondo Scalo, 00015 Rome, Italy.
  • Tocci A; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144 Rome, Italy.
  • Musella M; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144 Rome, Italy.
  • Sistigu A; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Nisticò P; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Chianesi 53, 00144 Rome, Italy.
Biology (Basel) ; 10(9)2021 Sep 14.
Article en En | MEDLINE | ID: mdl-34571790
Chronic viral infection and cancer are closely inter-related and are both characterized by profound alteration of tissue homeostasis. The actin cytoskeleton dynamics highly participate in tissue homeostasis and act as a sensor leading to an immune-mediated anti-cancer and anti-viral response. Herein we highlight the crucial role of actin cytoskeleton dynamics in participating in a viral mimicry activation with profound effect in anti-tumor immune response. This still poorly explored field understands the cytoskeleton dynamics as a platform of complex signaling pathways which may regulate Type I IFN response in cancer. This emerging network needs to be elucidated to identify more effective anti-cancer strategies and to further advance the immuno-oncology field which has revolutionized the cancer treatment. For a progress to occur in this exciting arena we have to shed light on actin cytoskeleton related pathways and immune response. Herein we summarize the major findings, considering the double sword of the immune response and in particular the role of Type I IFN pathways in resistance to anti-cancer treatment.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biology (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biology (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza